Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

Presentation TCT 2023

Occlutech PFO Occluder

Presenter: David Hildick-Smith

October 25, 2023

Nurse Practitioners Doing TAVI? What’s Gained, What’s Lost

News Features

Nurse Practitioners Doing TAVI? What’s Gained and Lost

Shelley Wood

June 16, 2023

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

Presentation TCT 2019

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

Presenter: David Hildick-Smith

September 26, 2019

Presentation TCT 2019

Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary

Presenter: David Hildick-Smith

September 26, 2019

News Conference News EuroPCR 2019

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Michael O'Riordan

May 22, 2019

Presentation TCT 2018

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Presenter: James B. Hermiller Jr, David Hildick-Smith, George S. Hanzel

September 24, 2018

Presentation TCT 2018

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Presenter: James B. Hermiller Jr, David Hildick-Smith, Martin W. Bergmann

September 24, 2018

Presentation TCT 2018

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Presenter: James B. Hermiller Jr, David Hildick-Smith, Jacqueline Saw

September 24, 2018

Presentation TCT 2018

Shared Decision-making in NVAF: The Patients Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, Megan Coylewright

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Presenter: James B. Hermiller Jr, David Hildick-Smith, David R. Holmes Jr.

September 24, 2018

Presentation TCT 2018

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Presenter: James B. Hermiller Jr, David Hildick-Smith, Freek W.A. Verheugt

September 24, 2018

Presentation TCT 2018

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Presenter: James B. Hermiller Jr, David Hildick-Smith, David E. Thaler

September 24, 2018

Presentation TCT 2018

Case# 2: Should This PFO Be Closed in a Patient With a TIA?

Presenter: Michael J. Mullen, David E. Thaler, Joseph P. Carrozza Jr, Ted Feldman, Craig E Fleishman, David Hildick-Smith, Jacqueline Saw, Jochen Wöhrle

September 22, 2018

Presentation TCT 2018

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

Presenter: David Hildick-Smith, Martin B. Leon, Giuseppe Biondi-Zoccai

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Presentation TCT 2018

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Presenter: David Hildick-Smith, Martin B. Leon, Andrejs Erglis

September 21, 2018

Advertisement

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Occlutech PFO Occluder

Nurse Practitioners Doing TAVI? What’s Gained and Lost

ACS After TAVR a Unique Condition With Poor Prognosis

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

Strokes After TAVR Are Rare and Cerebral Protection Is Unnecessary

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

Clip-Based Tricuspid Repair Improves Regurgitation, Function, and Quality of Life: TRILUMINATE

Managing a Busy LAA Closure Program: Patient Selection, Education, Consent, Screening, and Periprocedural Care

Adjunctive Pharmacology Following LAA Closure in Anticoagulant Indicated and Contraindicated Patients

Essential of Pre-procedural Imaging and Intra-procedural Guidance

Shared Decision-making in NVAF: The Patients Perspective

Debate: Is LAA Closure a Valid Alternative for Patients with No or Mild Contraindications to Anticoagulants? Yes - LAA Closure Reduces Hemorrhagic Stroke and Mortality And Nearly Everyone Has a Reason Not to Take Oral Anticoagulants!

Debate: Is LAA Closure a Valid Alternative for Patients With No or Mild Contraindications to Anticoagulants? No NOACs Are Strongly Preferred to LAA Closure!

Stroke Etiology, LAA Closure, and the Therapeutic Landscape: A Neurologists Perspective

Case# 2: Should This PFO Be Closed in a Patient With a TIA?

TCT-44: Comparative Effectiveness and Safety of Five Leading New-Generation TAVI Devices: 12-Month Results from The RISPEVA Study

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

TCT-43: First-In-Human Experience of a Novel Transradial Device for Embolic Deflection During Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content